M. Kreiner

527 total citations
27 papers, 435 citations indexed

About

M. Kreiner is a scholar working on Molecular Biology, Spectroscopy and Immunology and Allergy. According to data from OpenAlex, M. Kreiner has authored 27 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Spectroscopy and 7 papers in Immunology and Allergy. Recurrent topics in M. Kreiner's work include Enzyme Catalysis and Immobilization (7 papers), Cell Adhesion Molecules Research (7 papers) and Analytical Chemistry and Chromatography (6 papers). M. Kreiner is often cited by papers focused on Enzyme Catalysis and Immobilization (7 papers), Cell Adhesion Molecules Research (7 papers) and Analytical Chemistry and Chromatography (6 papers). M. Kreiner collaborates with scholars based in United Kingdom, Austria and Hungary. M. Kreiner's co-authors include Linda M. Harvey, Brian McNeil, Barry D. Moore, Christopher F. van der Walle, Anna De Raadt, Herfried Griengl, Helen J. Mardon, G. Braunegg, M. Petsch and Sharon M. Kelly and has published in prestigious journals such as Applied and Environmental Microbiology, Chemical Communications and Biochemical and Biophysical Research Communications.

In The Last Decade

M. Kreiner

26 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Kreiner United Kingdom 13 292 73 54 45 42 27 435
Aaron Watts United Kingdom 4 261 0.9× 63 0.9× 26 0.5× 32 0.7× 77 1.8× 7 493
Bogdan Kralj Slovenia 12 162 0.6× 116 1.6× 38 0.7× 32 0.7× 24 0.6× 24 438
Ivanka Stoineva Bulgaria 15 282 1.0× 36 0.5× 61 1.1× 20 0.4× 44 1.0× 37 560
Lihua Jin United States 15 388 1.3× 31 0.4× 59 1.1× 23 0.5× 76 1.8× 24 634
Christelle Mathé France 13 291 1.0× 30 0.4× 39 0.7× 61 1.4× 63 1.5× 17 602
Bryan J. Jones United States 10 377 1.3× 56 0.8× 65 1.2× 21 0.5× 71 1.7× 16 535
Enrique Carredano Sweden 10 467 1.6× 75 1.0× 60 1.1× 34 0.8× 69 1.6× 13 810
Marlen Schmidt Germany 17 664 2.3× 73 1.0× 143 2.6× 55 1.2× 56 1.3× 32 782
Lutz Haalck Germany 14 494 1.7× 105 1.4× 58 1.1× 26 0.6× 48 1.1× 24 662
David Silverman United States 10 248 0.8× 27 0.4× 19 0.4× 33 0.7× 25 0.6× 13 424

Countries citing papers authored by M. Kreiner

Since Specialization
Citations

This map shows the geographic impact of M. Kreiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Kreiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Kreiner more than expected).

Fields of papers citing papers by M. Kreiner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Kreiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Kreiner. The network helps show where M. Kreiner may publish in the future.

Co-authorship network of co-authors of M. Kreiner

This figure shows the co-authorship network connecting the top 25 collaborators of M. Kreiner. A scholar is included among the top collaborators of M. Kreiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Kreiner. M. Kreiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kreiner, M., Heather J. Bax, Jitesh Chauhan, et al.. (2025). Assessment of biophysical properties of the first-in-class anti-cancer IgE antibody drug MOv18 IgE demonstrates monomeric purity and stability. mAbs. 17(1). 2512211–2512211. 1 indexed citations
2.
Kreiner, M., et al.. (2011). Perfusion culture enhanced human endometrial stromal cell growth in alginate‐multivalent integrin α5β1 ligand scaffolds. Journal of Biomedical Materials Research Part A. 99A(2). 211–220. 11 indexed citations
3.
Kreiner, M., et al.. (2011). Clustered integrin α5β1 ligand displays model fibronectin-mediated adhesion of human endometrial stromal cells. Biochemical and Biophysical Research Communications. 407(4). 777–782. 6 indexed citations
4.
Patwardhan, Siddharth V., Stephen A. Holt, Sharon M. Kelly, et al.. (2010). Silica Condensation by a Silicatein α Homologue Involves Surface-Induced Transition to a Stable Structural Intermediate Forming a Saturated Monolayer. Biomacromolecules. 11(11). 3126–3135. 11 indexed citations
5.
Kreiner, M., et al.. (2009). Oligomerisation and thermal stability of polyvalent integrin α5β1 ligands. Biophysical Chemistry. 142(1-3). 34–39. 5 indexed citations
6.
Kreiner, M., et al.. (2009). Dimeric integrin α5β1 ligands confer morphological and differentiation responses to murine embryonic stem cells. Biochemical and Biophysical Research Communications. 390(3). 716–721. 6 indexed citations
7.
Beattie, James, et al.. (2009). IGFBP-3 and IGFBP-5 associate with the cell binding domain (CBD) of fibronectin. Biochemical and Biophysical Research Communications. 381(4). 572–576. 14 indexed citations
8.
Kreiner, M., Z. Li, James Beattie, et al.. (2008). Self-assembling multimeric integrin  5 1 ligands for cell attachment and spreading. Protein Engineering Design and Selection. 21(9). 553–560. 16 indexed citations
9.
Kreiner, M., et al.. (2006). A rapid and direct method for the determination of active site accessibility in proteins based on ESI‐MS and active site titrations. Biotechnology and Bioengineering. 95(4). 767–771. 4 indexed citations
10.
Kreiner, M., et al.. (2005). Protein-coated Microcrystals for use in Organic Solvents: Application to Oxidoreductases. Biotechnology Letters. 27(20). 1571–1577. 28 indexed citations
11.
Kreiner, M., et al.. (2005). Stability of protein-coated microcrystals in organic solvents. Journal of Molecular Catalysis B Enzymatic. 33(3-6). 65–72. 19 indexed citations
12.
Kreiner, M., et al.. (2004). High‐activity biocatalysts in organic media: solid‐state buffers as the immobilisation matrix for protein‐coated microcrystals. Biotechnology and Bioengineering. 87(1). 24–33. 25 indexed citations
13.
Kreiner, M., Linda M. Harvey, & Brian McNeil. (2003). Morphological and enzymatic responses of a recombinant Aspergillus niger to oxidative stressors in chemostat cultures. Journal of Biotechnology. 100(3). 251–260. 35 indexed citations
14.
Kreiner, M., Linda M. Harvey, & Brian McNeil. (2002). Oxidative stress response of a recombinant Aspergillus niger to exogenous menadione and H2O2 addition. Enzyme and Microbial Technology. 30(3). 346–353. 52 indexed citations
15.
Kreiner, M., et al.. (2001). Enzyme-coated micro-crystals: a 1-step method for high activity biocatalyst preparation. Chemical Communications. 1096–1097. 75 indexed citations
16.
Kreiner, M., Brian McNeil, & Linda M. Harvey. (2000). “Oxidative stress” response in submerged cultures of a recombinantAspergillus niger(B1-D). Biotechnology and Bioengineering. 70(6). 662–669. 27 indexed citations
17.
Kreiner, M., et al.. (1997). Influence of Additives on the Biohydroxylation of Protected Carboxylic Acids and Ketones. Food Technology and Biotechnology. 35. 99–102. 6 indexed citations
18.
19.
Kreiner, M., G. Braunegg, Anna De Raadt, et al.. (1996). Stereospecific Biohydroxylations of Protected Carboxylic Acids with Cunninghamella blakesleeana. Applied and Environmental Microbiology. 62(7). 2603–2609. 16 indexed citations
20.
Raadt, Anna De, Herfried Griengl, M. Petsch, et al.. (1996). Microbial hydroxylation of 2-cycloalkylbenoxazoles. Part II. Determination of product structures and enhancement of enantiomeric excess. Tetrahedron Asymmetry. 7(2). 473–490. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026